The Department of Justice has filed a federal civil complaint alleging a Medicare billing scheme that seeks $4,591,003 in recovery and ties into a larger 2026 National Health Care Fraud Takedown.
Federal prosecutors in the District of South Dakota allege a pattern of false claims and false statements submitted to Medicare involving a North Carolina resident and a Dallas-based company. The complaint centers on billing for implanted neurostimulation devices when investigators say temporary, non‑surgical electro‑acupuncture devices were used instead. The government is pursuing $4,591,003 in recovery from the parties named in the complaint.
According to the filing, Michael Bingham, 72, of Laurel Springs, North Carolina, and NeuroSolutions 100, LLC, of Dallas, Texas, are the defendants. Prosecutors say NeuroSolutions 100 billed Medicare for surgical implantation of electro‑neurostimulators while the actual treatment used adhesive devices placed behind the ear or needles similar to acupuncture. That distinction is the basis for the False Claims Act allegations in the civil case.
Investigators from the U.S. Department of Health and Human Services Office of the Inspector General and the Centers for Medicare and Medicaid Services reviewed the billing and clinical records that led to the complaint. Assistant U.S. Attorney Anne Weyer is handling litigation for the government in federal court. The complaint is civil in nature, and the defendants are presumed innocent until liability is established at trial.
“We’ve been directed by the Attorney General to do everything possible to eliminate fraud against the government and seek to recover funds stolen from taxpayers,” said U.S. Attorney Parsons. “That is what we are doing—and I am incredibly proud of our Assistant United States Attorneys and our entire team of legal specialists who are working so hard to accomplish that mission.”
The complaint is presented as part of the Justice Department’s coordinated 2026 National Health Care Fraud Takedown, a multiagency effort described by officials as unprecedented in scale. That takedown produced charges in 56 federal districts and across 45 states and territories, with law enforcement pursuing both domestic and international targets. Authorities say the broader operation involved 455 defendants, including 90 doctors and other licensed medical professionals.
Department statements tied to the operation cite more than $6.5 billion in alleged false claims and significant patient harm, including deaths in some matters. The enforcement sweep also used data analytics to identify high‑risk patterns, leading to seizures of cash, homes, luxury vehicles, and jewelry totaling over $182 million in assets. International cooperation led to apprehensions tied to multi‑billion dollar schemes in several countries.
Officials provided further figures to show the scope of coordinated actions: CMS suspended 1,079 providers and revoked billing privileges for 1,403 providers; there were 48 Civil Monetary Payment settlements totaling over $73 million; HHS‑OIG pursued more than $10 billion under the Civil Monetary Penalties Law; and civil charges or settlements included civil claims against 13 defendants for $14.8 million and settlements with 31 defendants totaling $23 million. The Drug Enforcement Administration initiated 928 administrative cases seeking to revoke authority to handle or prescribe controlled substances since October 1, 2025.
“This year’s National Health Care Fraud Takedown represents the greatest whole-of-government effort to combat health care fraud in our Nation’s history,” said Acting Attorney General Todd Blanche. “Under the decisive leadership of President Donald Trump, Vice President JD Vance, the White House Task Force to Eliminate Fraud, and our law enforcement partners, this administration has ushered in a new era of enforcement that will safeguard taxpayer dollars.”
A civil complaint is merely an allegation. All defendants are presumed innocent until proven liable in a court of law.
